289 related articles for article (PubMed ID: 3615491)
1. Survival rates and properties of sickle cell anemia red cells treated with nitrogen mustard.
Roth EF; Wenz B; Lee HB; Fabry M; Chang H; Kaul DK; Baez S; Nagel RL
Prog Clin Biol Res; 1987; 240():245-61. PubMed ID: 3615491
[TBL] [Abstract][Full Text] [Related]
2. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
[TBL] [Abstract][Full Text] [Related]
3. Established and experimental treatments for sickle cell disease.
De Franceschi L; Corrocher R
Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
[TBL] [Abstract][Full Text] [Related]
4. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
Ueda Y; Bookchin RM
J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
[TBL] [Abstract][Full Text] [Related]
5. Rate of deoxygenation modulates rheologic behavior of sickle red blood cells at a given mean corpuscular hemoglobin concentration.
Kaul DK; Liu XD
Clin Hemorheol Microcirc; 1999; 21(2):125-35. PubMed ID: 10599596
[TBL] [Abstract][Full Text] [Related]
6. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
[TBL] [Abstract][Full Text] [Related]
7. Effects of methyl acetyl phosphate, a covalent antisickling agent, on the density profiles of sickle erythrocytes.
Ueno H; Yatco E; Benjamin LJ; Manning JM
J Lab Clin Med; 1992 Jul; 120(1):152-8. PubMed ID: 1613320
[TBL] [Abstract][Full Text] [Related]
8. Current status of methyl acetimidate as an extracorporeal antisickling agent.
Chao TL; Berenfeld MR; Gabuzda TG
Am J Pediatr Hematol Oncol; 1984; 6(1):55-8. PubMed ID: 6711765
[TBL] [Abstract][Full Text] [Related]
9. Effects of erythrocytapheresis transfusion on the viscoelasticity of sickle cell blood.
Thurston GB; Henderson NM; Jeng M
Clin Hemorheol Microcirc; 2004; 30(1):61-75. PubMed ID: 14967885
[TBL] [Abstract][Full Text] [Related]
10. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
Noguchi CT; Rodgers GP; Schechter AN
Prog Clin Biol Res; 1987; 240():381-91. PubMed ID: 3615501
[TBL] [Abstract][Full Text] [Related]
11. Rheological assessment of antisickling effects of pyridoxine and pyridoxal.
Kuranstin-Mills J; Lessin LS
Blood Cells; 1982; 8(2):315-28. PubMed ID: 7159755
[TBL] [Abstract][Full Text] [Related]
12. Identification of 2-imidazolines as anti-sickling agents.
Chang H; Ewert SM; Nagel RL
Mol Pharmacol; 1983 May; 23(3):731-4. PubMed ID: 6865916
[TBL] [Abstract][Full Text] [Related]
13. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
Rodgers GP
Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal treatment with cyanate in sickle cell disease: preliminary observations in four patients.
Langer EE; Stamatoyannopoulos G; Hlastala MP; Adamson JW; Figley M; Labbe RF; Detter JC; Finch CA
J Lab Clin Med; 1976 Mar; 87(3):462-74. PubMed ID: 1249477
[TBL] [Abstract][Full Text] [Related]
15. Effects of red cell membrane on the polymerization of sickle hemoglobin.
Goldberg MA; Lalos AT; Himmelstein B; Bunn HF
Blood Cells; 1982; 8(2):237-43. PubMed ID: 7159748
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of GSTA2 protects against cell cycle arrest and apoptosis induced by the DNA inter-strand crosslinking nitrogen mustard, mechlorethamine.
Xie J; Shults K; Flye L; Jiang F; Head DR; Briggs RC
J Cell Biochem; 2005 May; 95(2):339-51. PubMed ID: 15778998
[TBL] [Abstract][Full Text] [Related]
17. [Dynamic study of osmotic resistance of red cells in sickle cell anemia (author's transl)].
Juhan I; Isnard G; Aquaron R
Pathol Biol (Paris); 1976 Sep; 24(7):451-5. PubMed ID: 790270
[TBL] [Abstract][Full Text] [Related]
18. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds.
Safo MK; Abdulmalik O; Danso-Danquah R; Burnett JC; Nokuri S; Joshi GS; Musayev FN; Asakura T; Abraham DJ
J Med Chem; 2004 Sep; 47(19):4665-76. PubMed ID: 15341482
[TBL] [Abstract][Full Text] [Related]
20. Effect of transfusion on hemoglobin flow and oxygen delivery in patients with sickle cell anemia--in vitro evaluation.
McIntire LV; Leverett LB; Alfrey CP; Lynch EC; Zanger B
Med Res Eng; 1980; 13(2):27-31. PubMed ID: 7401985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]